Correlation Between Unicycive Therapeutics and Apple

Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Apple at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Apple into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Unicycive Therapeutics and Apple Inc, you can compare the effects of market volatilities on Unicycive Therapeutics and Apple and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Apple. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Apple.

Diversification Opportunities for Unicycive Therapeutics and Apple

0.79

Correlation Coefficient

Unicycive Therapeutics  Apple

Poor diversification

The 3 months correlation between Unicycive and Apple is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Apple Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apple Inc and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Apple. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apple Inc has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Apple go up and down completely randomly.

Pair Corralation between Unicycive Therapeutics and Apple

Given the investment horizon of 90 days Unicycive Therapeutics is expected to generate 7.15 times more return on investment than Apple. However, Unicycive Therapeutics is 7.15 times more volatile than Apple Inc. It trades about 0.04 of its potential returns per unit of risk. Apple Inc is currently generating about 0.11 per unit of risk. If you would invest  50.00  in Unicycive Therapeutics on September 24, 2024 and sell it today you would earn a total of  18.40  from holding Unicycive Therapeutics or generate 36.8% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	99.8%
Values	Daily Returns

Unicycive Therapeutics  vs.  Apple Inc

Unicycive Therapeutics

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Unicycive Therapeutics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady fundamental indicators, Unicycive Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Apple Inc

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Apple Inc are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite quite uncertain basic indicators, Apple may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Unicycive Therapeutics and Apple

The main advantage of trading using opposite Unicycive Therapeutics and Apple positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Apple can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apple will offset losses from the drop in Apple's long position.

The idea behind Unicycive Therapeutics and Apple Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.